A comparative study to alternatives to the log-rank test
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),General Medicine
Reference46 articles.
1. PRM39 Survival curve convergences and crossing: a threat to validity of meta-analysis;Kristiansen;Value Health,2012
2. Comparison of treatment effects measured by the hazard ratio and by the ratio of restricted mean survival times in oncology randomized controlled trials;Trinquart;J. Clin. Oncol.,2016
3. Statistical challenges in the design of late-stage cancer immunotherapy studies;Mick;Cancer Immunol. Res.,2015
4. Hazards of hazard ratios-deviations from model assumptions in immunotherapy;Alexander;N. Engl. J. Med.,2018
5. A Simulation Study Comparing the Power of Nine Tests of the Treatment Effect in Randomized Controlled Trials with a Time-to-Event Outcome;Royston;Trials,2020
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diversity in clinical isolates of Ictalurid herpesvirus 1 (IcHV1) from U.S. farm‐raised catfish and virulence assessment in channel and channel × blue catfish hybrids;Journal of Fish Diseases;2024-08-11
2. Nonparametric test for multiple crossing Survival Curves;VFAST Transactions on Mathematics;2024-06-30
3. Advances in AI-based genomic data analysis for cancer survival prediction;Multimedia Tools and Applications;2024-06-21
4. Methods for non-proportional hazards in clinical trials: A systematic review;Statistical Methods in Medical Research;2024-04-09
5. Competing Risks: Concepts, Methods, and Software;Annual Review of Statistics and Its Application;2023-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3